Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022

SELL
$187.51 - $283.98 $671,848 - $1.02 Million
-3,583 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$238.08 - $288.0 $429,496 - $519,552
1,804 Added 101.41%
3,583 $1.03 Million
Q3 2021

Nov 12, 2021

SELL
$250.72 - $291.24 $32,844 - $38,152
-131 Reduced 6.86%
1,779 $474,000
Q2 2021

Aug 12, 2021

BUY
$235.0 - $310.7 $448,850 - $593,437
1,910 New
1,910 $523,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.01B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Bank Of Nova Scotia Portfolio

Follow Bank Of Nova Scotia and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Nova Scotia with notifications on news.